.

Efficacy and Safety of Enoxaparin 20 Mg Subcutaneously in Patients With Chronic Kidney Disease Stages 4 and 5 for Deep Vein Thrombosis Prophylaxis

LAUR Repository

Efficacy and Safety of Enoxaparin 20 Mg Subcutaneously in Patients With Chronic Kidney Disease Stages 4 and 5 for Deep Vein Thrombosis Prophylaxis

Karaoui, Lamis; Tawil, Samah
URI: http://hdl.handle.net/10725/4464
URL: https://journals.lww.com/ccmjournal/Fulltext/2011/12001/801__EFFICACY_AND_SAFETY_OF_ENOXAPARIN_20_MG.757.aspx
DOI: http://dx.doi.org/10.1097/01.ccm.0000408627.24229.88
Date: 2016-09-30
Terms of Use: This item is made available under the terms and conditions applicable to " Article ", as set forth at: http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php

Citation:

Karaoui, L., & Tawil, S. (2011). Efficay and safety of Enoxaparin 20 mg subcutaneously in patients with chronic kidney disease stages 4 and 5 for deep vein thrombosis prophylaxis. Critical Care Medicine, 39(12), 225.

Access Status:

N/A

Show full item record

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search LAUR


Advanced Search

Browse

My Account